Animal Models Core
- Institution
- OKLAHOMA STATE UNIVERSITY STILLWATER, OK
- Principal investigator
- Myron E Hinsdale
- Funding
- $153K
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
Animal Models Core Project Summary: Centers of Biomedical Research Excellence Phase I and II funding for the animal models core (AMC) established a research core with expertise in respiratory and infectious diseases, including state-of-the-art equipment and animal biosafety level 2 (ABSL-2) housing and procedural facilities. With Phase III the AMC will be expanding its services for the ABSL-2 studies with new cutting-edge equipment for phenotyping of animal models of respiratory and infectious disease. In addition, the AMC will be expanding its services to ABSL-3 animal models to better address the urgent needs for BSL3 research at the state level as well as the national level. The central objective of this Phase III proposal is to strengthen the existing BSL2 infrastructure and services and enhance the AMC with ABSL-3 capabilities to adapt to the expanding needs in respiratory and infectious disease research in Oklahoma. The aims of this proposal are: i) Aim 1: Provide a state-of-the-art ABSL-2/3 service to CoBRE pilot projects and other Oklahoma researchers; ii) Aim 2: Provide ABSL-2/3 experimental and regulatory training to CoBRE investigators; iii) Aim 3: Develop a sustainable and independent ABSL-2/3 AMC for use beyond Phase III funding. As a result of Phase III activities, the AMC will increase interdisciplinary interactions between and training of Oklahoma Center for Respiratory Infectious Disease (OCRID) researchers at Oklahoma State University, University of Oklahoma and Oklahoma Medical Research Foundation.
LOADING MOONBASE SCORE
Questions for OKLAHOMA STATE UNIVERSITY STILLWATER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Oklahoma State University Stillwater48
Engineering host-determinants of novel gut Microviruses
Paul Kirchberger · $241K · 2024–2029
- NIH · Oklahoma State University Stillwater48
Defining the Translocation Mechanisms of SARS-CoV-2 nsp13 Helicase to Aid in Antiviral Development
Martin Mccullagh · $437K · 2021–2026
- NIH · Oklahoma State University Stillwater48
SCH: Harnessing Tensor Information to Improve EHR Data Quality for Accurate Data-driven Screening of Diabetic Retinopathy with Routine Lab Results
Tieming Liu · $67K · 2021–2026